INTERNATIONAL PATENT: NEOWISE BIOTECHNOLOGY CO., LTD., 新景智源生物科技（苏州）有限公司 FILES APPLICATION FOR "KRAS_G12D MUTANT ANTIGEN-SPECIFIC TCR AND CO-EXPRESSION OF TCR AND CD8 TO REDIRECT CD4 T CELLS"

Posted On: 2025-06-23

GENEVA, June 23 -- NEOWISE BIOTECHNOLOGY CO., LTD. (Rm401, Bldg. 2, BioBay 3B, 99 Jingu Road, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 新景智源生物科技（苏州）有限公司 (中国江苏省苏州市苏州工业园区金谷路99号生物产业园三期B区2栋401) filed a patent application (PCT/CN2024/138852) for "KRAS_G12D MUTANT ANTIGEN-SPECIFIC TCR, AND CO-EXPRESSION OF TCR AND CD8 TO REDIRECT CD4 T CELLS" on Dec 12, 2024. With publication no. WO/2025/124489, the details related to the patent application was p...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: NEOWISE BIOTECHNOLOGY CO., LTD., 新景智源生物科技（苏州）有限公司 FILES APPLICATION FOR "KRAS_G12D MUTANT ANTIGEN-SPECIFIC TCR AND CO-EXPRESSION OF TCR AND CD8 TO REDIRECT CD4 T CELLS"